Rezolute to participate in upcoming virtual healthcare conferences

Redwood city, calif., aug. 03, 2021 (globe newswire) -- rezolute, inc. (nasdaq: rzlt), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, today announced that nevan charles elam, ceo and founder, will present at two upcoming virtual investment conferences.

RZLT Ratings Summary

RZLT Quant Ranking